1
|
Arslan T, Senturk M, Karagoz L, Karagoz Y, Ekinci D, Efe A, Türkoğlu EA, Uras F. Synthesis
, in vitro
and
in silico
Biological Studies of Sulfonamide Chalcones as Esterase Inhibitors. ChemistrySelect 2022. [DOI: 10.1002/slct.202202993] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- Tayfun Arslan
- Department of Chemistry Faculty of Science and Art Giresun University 28200 Giresun Türkiye
| | - Murat Senturk
- Department of Biochemistry Faculty of Pharmacy Agri Ibrahim Cecen University 04100 Agri Türkiye
| | - Lütfi Karagoz
- Department of Biochemistry Faculty of Pharmacy Marmara University 34668 Istanbul Türkiye
| | - Yalcin Karagoz
- Department of Biochemistry Faculty of Pharmacy Agri Ibrahim Cecen University 04100 Agri Türkiye
| | - Deniz Ekinci
- Department of Agricultural Biotechnology Faculty of Agriculture Ondokuz Mayıs University 55139 Samsun Türkiye
| | - Asiye Efe
- Institute of Graduate Education Agri Ibrahim Cecen University 04100 Agri Türkiye
| | - Emir Alper Türkoğlu
- Department of Pharmaceutical Biotechnology Faculty of Pharmacy University of Health Sciences Turkey 34668 Istanbul Türkiye
| | - Fikriye Uras
- Department of Biochemistry Faculty of Pharmacy Marmara University 34668 Istanbul Türkiye
| |
Collapse
|
2
|
The potential of chalcone derivatives as human carbonic anhydrase inhibitors in the therapy of glaucoma. Med Chem Res 2022. [DOI: 10.1007/s00044-022-02978-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
3
|
Radder SB, Melavanki R, Radder U, Hiremath SM, Kusanur R, Khemalapure SS. Synthesis, spectroscopic (FT-IR, FT-Raman, NMR), reactivity (ELF, LOL and Fukui) and docking studies on 3-(2‑hydroxy-3‑methoxy-phenyl)-1-(3-nitro-phenyl)-propenone by experimental and DFT methods. J Mol Struct 2022. [DOI: 10.1016/j.molstruc.2022.132443] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
4
|
Sharma K, Melavanki R, Hiremath SM, Kusanur R, Geethanjali H, D N. Synthesis, spectroscopic characterization, electronic and docking studies on novel chalcone derivatives (3DPP and 5PPD) by experimental and DFT methods. J Mol Struct 2022. [DOI: 10.1016/j.molstruc.2022.132553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
5
|
TAŞKIN T, KAHVECİOĞLU D, TÜRKOĞLU EA, DOĞAN A, KUZU M. In vitro Biological Activities of Different Extracts from Alcea dissecta. CLINICAL AND EXPERIMENTAL HEALTH SCIENCES 2022. [DOI: 10.33808/clinexphealthsci.787845] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
6
|
Patil P, Melavanki R, Radder SB, Kusanur R, Hiremath CS, Patil NR, Hiremath SM. Synthesis, Structural Characterizations, and Quantum Chemical Investigations on 1-(3-Methoxy-phenyl)-3-naphthalen-1-yl-propenone. ACS OMEGA 2021; 6:25982-25995. [PMID: 34660960 PMCID: PMC8515393 DOI: 10.1021/acsomega.1c02688] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/31/2021] [Accepted: 09/15/2021] [Indexed: 05/05/2023]
Abstract
In the present study, 1-(3-methoxy-phenyl)-3-naphthalen-1-yl-propenone (MPNP) is synthesized and characterized by several experimental techniques such as Fourier transform-infrared spectroscopy (FT-IR), FT-Raman, NMR and UV-vis spectral methods. The similar techniques are also investigated by the computational method using Gaussian software. The density functional theory (DFT) method is used to obtain the optimized structure using the B3LYP/6-311++G(d,p) basis set. This optimization procedure of the molecule gives the minimum energy confirmation of the structure. The computed geometrical parameters are compared with experimental data. The experimental FT-IR and FT-Raman spectra of MPNP are obtained in the regions 4000-400 and 4000-50 cm-1 respectively. The detailed vibrational assignments of the molecule are obtained with the support of potential energy distribution. The theoretical NMR (1H and 13C) analysis is conducted by the GIAO method for its structural characterization and compared with experimental chemical shifts. The experimental UV-vis spectrum is obtained in the dimethyl sulfoxide solvent and compared with the theoretically computed spectrum by the time-dependent DFT method. In addition to these studies, other analyses such as nonlinear optical, natural bonds orbital, frontier molecular orbital, molecular electrostatic potential, and NCI have been conducted to understand the nature of the molecule. The title molecule is docked and also the drug-likeness, ADMET studies were carried out. The RBD domain bound to the ACE2 receptor during the fusion makes spike glycoprotein an elusive therapeutic target in SARS-CoV-2 infection.
Collapse
Affiliation(s)
- Prakashgouda
G. Patil
- Department
of Physics, J. T. College, Gadag 582102, Karnataka, India
- Department
of Physics, Visvesvaraya Technological University, Belgavi 590018, Karnataka, India
| | - Raveendra Melavanki
- Department
of Physics, M S Ramaiah Institute of Technology, Bangalore 560054, Karnataka, India
- Department
of Physics, Visvesvaraya Technological University, Belgavi 590018, Karnataka, India
| | - Shivaraj B. Radder
- Department
of Physics, M S Ramaiah Institute of Technology, Bangalore 560054, Karnataka, India
- Department
of Physics, Visvesvaraya Technological University, Belgavi 590018, Karnataka, India
| | - Raviraj Kusanur
- Department
of Chemistry, RV College of Engineering, Bangalore 560059, Karnataka, India
| | | | - Ninganagouda R. Patil
- Department
of Physics, B V B College of Engineering
and Technology, Hubli 580031, Karnataka, India
- Department
of Physics, Visvesvaraya Technological University, Belgavi 590018, Karnataka, India
| | - Sudhir M. Hiremath
- Department
of P.G. Studies in Physics, J. T. College, Gadag 582102, Karnataka, India
- Department
of Physics, Visvesvaraya Technological University, Belgavi 590018, Karnataka, India
| |
Collapse
|
7
|
Design, synthesis of novel peripherally tetra-chalcone substituted phthalocyanines and their inhibitory effects on acetylcholinesterase and carbonic anhydrases (hCA I and II). J Organomet Chem 2021. [DOI: 10.1016/j.jorganchem.2021.122021] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
8
|
Güller P, Dağalan Z, Güller U, Çalışır U, Nişancı B. Enzymes inhibition profiles and antibacterial activities of benzylidenemalononitrile derivatives. J Mol Struct 2021. [DOI: 10.1016/j.molstruc.2021.130498] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
9
|
Antibacterial properties and carbonic anhydrase inhibition profiles of azido sulfonyl carbamate derivatives. Future Med Chem 2021; 13:1285-1299. [PMID: 34075799 DOI: 10.4155/fmc-2020-0387] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
Aim: The aim of this study was to identify inhibition of carbonic anhydrase I and II (CA I and II) isozymes by azido sulfonyl carbamates through both in vitro and in silico approaches and also to determine the drug-likeness properties and antibacterial activities of azido sulfonyl carbamates. Methods & Results: In vitro inhibition and molecular docking studies of azido sulfonyl carbamate derivatives (1-4) on isozymes were performed. Except for derivative 4, all derivatives inhibited human CA I and II. Almost all compounds had antibacterial effects. The docking results showed that compound 3 had the best results, with binding energy of -8.20 kcal/mol for human CA I and -8.24 kcal/mol for human CA II. Conclusion: Molecule 4 inhibited only CA I. Its usage as a potential chemotherapeutic agent specific to the CA I isozyme may be considered.
Collapse
|
10
|
Petrou A, Fesatidou M, Geronikaki A. Thiazole Ring-A Biologically Active Scaffold. Molecules 2021; 26:3166. [PMID: 34070661 PMCID: PMC8198555 DOI: 10.3390/molecules26113166] [Citation(s) in RCA: 67] [Impact Index Per Article: 22.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Revised: 05/15/2021] [Accepted: 05/20/2021] [Indexed: 11/16/2022] Open
Abstract
BACKGROUND Thiazole is a good pharmacophore nucleus due to its various pharmaceutical applications. Its derivatives have a wide range of biological activities such as antioxidant, analgesic, and antimicrobial including antibacterial, antifungal, antimalarial, anticancer, antiallergic, antihypertensive, anti-inflammatory, and antipsychotic. Indeed, the thiazole scaffold is contained in more than 18 FDA-approved drugs as well as in numerous experimental drugs. OBJECTIVE To summarize recent literature on the biological activities of thiazole ring-containing compounds Methods: A literature survey regarding the topics from the year 2015 up to now was carried out. Older publications were not included, since they were previously analyzed in available peer reviews. RESULTS Nearly 124 research articles were found, critically analyzed, and arranged regarding the synthesis and biological activities of thiazoles derivatives in the last 5 years.
Collapse
Affiliation(s)
| | | | - Athina Geronikaki
- School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; (A.P.); (M.F.)
| |
Collapse
|
11
|
Tugrak M, Gul HI, Akincioglu H, Gulcin I. New Chalcone Derivatives with Pyrazole and Sulfonamide Pharmacophores as Carbonic Anhydrase Inhibitors. LETT DRUG DES DISCOV 2021. [DOI: 10.2174/1570180817999201001160414] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Background:
Compound containing sulfonamide, pyrazole and chalcone groups are
important in medicinal chemistry. They have a wide range of biological activities, including carbonic
anhydrase (CA) inhibitory activities.
Introduction:
Carbonic anhydrase I and II inhibitors are used for the treatment of diseases, such as
retinal and cerebral edema (CA I), epilepsy, and glaucoma (CA II). However, the currently available
drugs have some limitations or side effects. Thus, there is a need for new drug candidates to
overcome these issues. In this study, a series of compounds, (E)-4-(4-(3-aryl)-3-oxoprop-1-en-1-yl)-
3-phenyl-1H-pyrazol-1-yl) benzenesulfonamides MS4-MS10, were designed to discover new CA
inhibitors using a hybrid approach.
Methods:
Compounds MS4-MS10 were synthesized as shown in Scheme 1, and their chemical
structures were confirmed by 1H NMR, 13C NMR, and HRMS spectra. The CAs (E.C.4.2.1.1) inhibitory
effects of MS4-MS10 were tested on the hCA I and II isoenzymes using previously reported
procedures.
Results:
The CA inhibitors MS4–MS10 gave IC50 values (nM) of 27.8–87.3 towards hCA I and
24.4–54.8 towards hCA II while the IC50 values for reference drug acetazolamide were 384.2 (hCA I)
and 36.9 (hCA II). MS7 and MS9 exhibited 13.8 (hCA I) and 1.5 (hCA II) times more potent CA
inhibition than the reference compound acetazolamide, respectively.
Conclusion:
MS7 (Ar: 2,4,5-trimethoxy phenyl) and MS9 (Ar: 3,4-dimethoxy phenyl) were the
most promising compounds of our series with the lowest IC50 values towards hCA I and hCA II,
respectively, and can be considered for further studies.
Collapse
Affiliation(s)
- Mehtap Tugrak
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ataturk University, Erzurum, Turkey
| | - Halise Inci Gul
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ataturk University, Erzurum, Turkey
| | - Hulya Akincioglu
- Department of Chemistry, Faculty of Sciences and Arts, Agri Ibrahim Cecen University, Agri, Turkey
| | - Ilhami Gulcin
- Department of Chemistry, Faculty of Science, Ataturk University, Erzurum, Turkey
| |
Collapse
|
12
|
Singh P, Purnachander Yadav P, Swain B, Thacker PS, Angeli A, Supuran CT, Arifuddin M. Discovery of a novel series of indolylchalcone-benzenesulfonamide hybrids acting as selective carbonic anhydrase II inhibitors. Bioorg Chem 2021; 108:104647. [PMID: 33530019 DOI: 10.1016/j.bioorg.2021.104647] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2020] [Revised: 12/11/2020] [Accepted: 01/06/2021] [Indexed: 01/12/2023]
Abstract
The primary sulfonamide group is one of the most efficient zinc binding group (ZBG) for designing carbonic anhydrase (CA, EC 4.2.1.1) inhibitors. In the present study primary sulfonamide linked with indolylchalcone were designed. The newly synthesized molecules (5a-r) were examined against four human (h) CA isoforms (hCA I, hCA II, hCA IX and hCA XIII). These sulfonamides showed good inhibition activity against isoforms hCA I, hCA II and hCA XIII. Compound 5i (2.3 nM), 5m (2.4 nM), 5o (3.6 nM) and 5q (7.0 nM) were more potent than standard drug AAZ (12.1 nM) against isoform hCA II, respectively. Most of the other compounds in the present series inhibited hCA XIII and hCA IX in the range of 50 nM - 100 nM.
Collapse
Affiliation(s)
- Priti Singh
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad 500037, India
| | - Parvatha Purnachander Yadav
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad 500037, India
| | - Baijayantimala Swain
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad 500037, India
| | - Pavitra S Thacker
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad 500037, India
| | - Andrea Angeli
- UniversitàdegliStudi di Firenze, Neurofarba Dept, Sezione di ScienzeFarmaceutiche e, Nutraceutiche, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy
| | - Claudiu T Supuran
- UniversitàdegliStudi di Firenze, Neurofarba Dept, Sezione di ScienzeFarmaceutiche e, Nutraceutiche, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy.
| | - Mohammed Arifuddin
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad 500037, India; Department of Chemistry, Anwarul Uloom College, 11-3-918, New Malleypally, Hyderabad-500001, T. S, India.
| |
Collapse
|
13
|
Wassel MM, Ragab A, Elhag Ali GA, Mehany AB, Ammar YA. Novel adamantane-pyrazole and hydrazone hybridized: Design, synthesis, cytotoxic evaluation, SAR study and molecular docking simulation as carbonic anhydrase inhibitors. J Mol Struct 2021. [DOI: 10.1016/j.molstruc.2020.128966] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
|
14
|
Dizdaroglu Y, Albay C, Arslan T, Ece A, Turkoglu EA, Efe A, Senturk M, Supuran CT, Ekinci D. Design, synthesis and molecular modelling studies of some pyrazole derivatives as carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2020; 35:289-297. [PMID: 31797703 PMCID: PMC6896446 DOI: 10.1080/14756366.2019.1695791] [Citation(s) in RCA: 34] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2019] [Revised: 11/11/2019] [Accepted: 11/13/2019] [Indexed: 11/08/2022] Open
Abstract
In this study, newly synthesised compounds 6, 8, 10 and other compounds (1-5, 7 and 9) and their inhibitory properties against the human isoforms hCA I and hCA II were reported for the first time. Compounds 1-10 showed effective inhibition profiles with KI values in the range of 5.13-16.9 nM for hCA I and of 11.77-67.39 nM against hCA II, respectively. Molecular docking studies were also performed with Glide XP to get insight into the inhibitory activity and to evaluate the binding modes of the synthesised compounds to hCA I and II. More rigorous binding energy calculations using MM-GBSA protocol which agreed well with observed activities were then performed to improve the docking scores. Results of in silico calculations showed that all compounds obey drug likeness properties. The new compounds reported here might be promising lead compounds for the development of new potent inhibitors as alternatives to classical hCA inhibitors.
Collapse
Affiliation(s)
- Yazgı Dizdaroglu
- Faculty of Science and Arts, Giresun University, Giresun, Turkey
| | - Canan Albay
- Faculty of Science and Arts, Giresun University, Giresun, Turkey
| | - Tayfun Arslan
- Faculty of Science and Arts, Giresun University, Giresun, Turkey
- Technical Sciences Vocational School, Giresun University, Giresun, Turkey
| | - Abdulilah Ece
- Faculty of Pharmacy, Biruni University, Istanbul, Turkey
| | - Emir A. Turkoglu
- Faculty of Pharmacy, University of Health Sciences, Istanbul, Turkey
| | - Asiye Efe
- Faculty of Pharmacy, Agri Ibrahim Cecen University, Agri, Turkey
| | - Murat Senturk
- Faculty of Pharmacy, Agri Ibrahim Cecen University, Agri, Turkey
| | | | - Deniz Ekinci
- Ondokuz Mayis University, Faculty of Agriculture, Department of Agricultural Biotechnology, Samsun, Turkey
| |
Collapse
|
15
|
Mishra CB, Tiwari M, Supuran CT. Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today? Med Res Rev 2020; 40:2485-2565. [PMID: 32691504 DOI: 10.1002/med.21713] [Citation(s) in RCA: 143] [Impact Index Per Article: 35.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2020] [Revised: 06/14/2020] [Accepted: 07/03/2020] [Indexed: 12/21/2022]
Abstract
Carbonic anhydrases (CAs, EC 4.2.1.1) are widely distributed metalloenzymes in both prokaryotes and eukaryotes. They efficiently catalyze the reversible hydration of carbon dioxide to bicarbonate and H+ ions and play a crucial role in regulating many physiological processes. CAs are well-studied drug target for various disorders such as glaucoma, epilepsy, sleep apnea, and high altitude sickness. In the past decades, a large category of diverse families of CA inhibitors (CAIs) have been developed and many of them showed effective inhibition toward specific isoforms, and effectiveness in pathological conditions in preclinical and clinical settings. The discovery of isoform-selective CAIs in the last decade led to diminished side effects associated with off-target isoforms inhibition. The many new classes of such compounds will be discussed in the review, together with strategies for their development. Pharmacological advances of the newly emerged CAIs in diseases not usually associated with CA inhibition (neuropathic pain, arthritis, cerebral ischemia, and cancer) will also be discussed.
Collapse
Affiliation(s)
- Chandra B Mishra
- Department of Bioorganic Chemistry, Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi, India.,Department of Pharmaceutical Chemistry, College of Pharmacy, Sookmyung Women's University, Seoul, South Korea
| | - Manisha Tiwari
- Department of Bioorganic Chemistry, Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi, India
| | - Claudiu T Supuran
- Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche, Università degli Studi di Firenze, Florence, Italy
| |
Collapse
|
16
|
Singh P, Swain B, Thacker PS, Sigalapalli DK, Purnachander Yadav P, Angeli A, Supuran CT, Arifuddin M. Synthesis and carbonic anhydrase inhibition studies of sulfonamide based indole-1,2,3-triazole chalcone hybrids. Bioorg Chem 2020; 99:103839. [DOI: 10.1016/j.bioorg.2020.103839] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2020] [Revised: 03/31/2020] [Accepted: 04/06/2020] [Indexed: 12/21/2022]
|
17
|
Kaya S, Gökce H, Arslan T, Alpaslan G. Synthesis, spectroscopic characterization, DFT computations, nonlinear optical profile and molecular docking study of a novel chalcone derivative. J Mol Struct 2020. [DOI: 10.1016/j.molstruc.2019.127270] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
18
|
Yang C, Feng Y, Yang X, Sun M, Li Z, Liu X, Lu L, Sun X, Zhang J, He X. Synthesis and evaluation of 4-(1,3,4-oxadiazol-2-yl)-benzenesulfonamides as potent carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2020; 30:126874. [PMID: 31859159 DOI: 10.1016/j.bmcl.2019.126874] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2019] [Revised: 11/23/2019] [Accepted: 11/27/2019] [Indexed: 01/08/2023]
Abstract
Human Carbonic anhydrase (hCA) I and II are crucial targets for anti-acute mountain sickness. Twenty-one 4-(1,3,4-oxadiazol-2-yl) benzenesulfonamides were synthesized and screened against these two isoforms. The results illustrated that 5c, 5g, 5h, 5k were more potent against both hCA I and II than clinical drug AAZ. In particular, the value of compound 5c with hCA I (18.08 nM) was over 84-fold more than of AAZ with hCA I. The data of docking simulations were also in accord with the tendency of inhibitive activities. Furthermore, compound 6h, the methanesulfonate of 5h, showed better anti-hypoxia activity than AAZ in vivo, making it interesting lead compound.
Collapse
Affiliation(s)
- Chaofu Yang
- College of Chemistry & Pharmacy, Shaanxi Key Laboratory of Natural Products & Chemical Biology, Northwest A&F University, Yangling, Shaanxi 712100, China; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27 Taiping Road, Haidian District, Beijing 100850, China
| | - Yan Feng
- College of Pharmacy, Hebei University, Baoding 071002, Hebei, China
| | - Xu Yang
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27 Taiping Road, Haidian District, Beijing 100850, China
| | - Mingxia Sun
- College of Chemistry & Pharmacy, Shaanxi Key Laboratory of Natural Products & Chemical Biology, Northwest A&F University, Yangling, Shaanxi 712100, China
| | - Zhenwang Li
- Department of Pharmacy, College of Animal Science and Technique, Heilongjiang Bayi Agricultural University, Daqing, China
| | - Xuan Liu
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27 Taiping Road, Haidian District, Beijing 100850, China
| | - Liang Lu
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27 Taiping Road, Haidian District, Beijing 100850, China
| | - Xianyu Sun
- Department of Pharmacy, College of Animal Science and Technique, Heilongjiang Bayi Agricultural University, Daqing, China
| | - Jiwen Zhang
- College of Chemistry & Pharmacy, Shaanxi Key Laboratory of Natural Products & Chemical Biology, Northwest A&F University, Yangling, Shaanxi 712100, China.
| | - Xinhua He
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27 Taiping Road, Haidian District, Beijing 100850, China.
| |
Collapse
|
19
|
Çelik G, Arslan T, Şentürk M, Ekinci D. Synthesis and characterization of some new pyrazolines and their inhibitory potencies against carbonic anhydrases. Arch Pharm (Weinheim) 2020; 353:e1900292. [DOI: 10.1002/ardp.201900292] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2019] [Revised: 12/18/2019] [Accepted: 12/21/2019] [Indexed: 12/23/2022]
Affiliation(s)
- Gonca Çelik
- Department of Chemistry, Faculty of ScienceKaradeniz Technical UniversityTrabzon Turkey
| | - Tayfun Arslan
- Department of Chemistry, Faculty of ScienceGiresun UniversityGiresun Turkey
| | - Murat Şentürk
- Department of Basic Sciences of Pharmacy, Faculty of PharmacyIbrahim Cecen UniversityAgri Turkey
| | - Deniz Ekinci
- Department of Agricultural Biotechnology, Faculty of AgricultureOndokuz Mayıs UniversitySamsun Turkey
| |
Collapse
|
20
|
Tandem chalcone-sulfonamide hybridization, cyclization and further Claisen–Schmidt condensation: Tuning molecular diversity through reaction time and order and catalyst. ARAB J CHEM 2020. [DOI: 10.1016/j.arabjc.2017.11.005] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
|
21
|
Custodio JMF, Moura AF, de Moraes MO, Perez CN, Napolitano HB. On the in silico and in vitro anticancer activity of sulfonamide chalcones: potential JNKK3 inhibitors. NEW J CHEM 2020. [DOI: 10.1039/c9nj05612b] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Although many compound classes have been studied as JNK inhibitors, we are interested in using chalcones for this purpose. Do different groups drive to different bindings modes to JNK?
Collapse
Affiliation(s)
- Jean M. F. Custodio
- Department of Chemistry and Biochemistry
- University of Notre Dame
- Notre Dame
- USA
- Instituto de Química
| | - Andrea F. Moura
- Núcleo de Pesquisas e Desenvolvimento de Medicamentos
- Universidade Federal do Ceará
- Fortaleza
- Brazil
- Núcleo de Pesquisa em Biotecnologia e Biodiversidade – BIOTEC
| | - Manoel O. de Moraes
- Núcleo de Pesquisas e Desenvolvimento de Medicamentos
- Universidade Federal do Ceará
- Fortaleza
- Brazil
| | | | | |
Collapse
|
22
|
Arslan T, Buğrahan Ceylan M, Baş H, Biyiklioglu Z, Senturk M. Design, synthesis, characterization of peripherally tetra-pyridine-triazole-substituted phthalocyanines and their inhibitory effects on cholinesterases (AChE/BChE) and carbonic anhydrases (hCA I, II and IX). Dalton Trans 2020; 49:203-209. [DOI: 10.1039/c9dt03897c] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
In this study, phthalocyanine precursors (5and9) and 1,2,3-triazole-substituted metal-free and metallo phthalocyanines (9a–c) were designed and synthesized for the first time and evaluatedin vitrofor key molecular targets.
Collapse
Affiliation(s)
- Tayfun Arslan
- Department of Chemistry
- Faculty of Sciences
- Giresun
- Turkey
- Department of Textile
| | | | - Hüseyin Baş
- Department of Chemistry
- Faculty of Science
- Karadeniz Technical University
- 61080 Trabzon
- Turkey
| | - Zekeriya Biyiklioglu
- Department of Chemistry
- Faculty of Science
- Karadeniz Technical University
- 61080 Trabzon
- Turkey
| | - Murat Senturk
- Department of Basic Sciences of Pharmacy
- Faculty of Pharmacy
- Agri Ibrahim Cecen University
- 04100 Agri
- Turkey
| |
Collapse
|
23
|
El-Azab AS, Abdel-Aziz AAM, Bua S, Nocentini A, Alanazi MM, AlSaif NA, Al-Suwaidan IA, Hefnawy MM, Supuran CT. Synthesis and comparative carbonic anhydrase inhibition of new Schiff's bases incorporating benzenesulfonamide, methanesulfonamide, and methylsulfonylbenzene scaffolds. Bioorg Chem 2019; 92:103225. [PMID: 31493707 DOI: 10.1016/j.bioorg.2019.103225] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2019] [Revised: 08/25/2019] [Accepted: 08/27/2019] [Indexed: 01/07/2023]
Abstract
Herein, we report the synthesis, characterization, and carbonic anhydrase (CA) inhibition of the newly synthesized Schiff's bases 4-18 with benzenesulfonamide, methanesulfonamide, and methylsulfonylbenzene scaffolds. The compound inhibition profiles against human CA (hCA) isoforms I, II, IX, and XII were compared to those of the standard inhibitors, acetazolamide (AAZ) and SLC-0111 (a CA inhibitor in Phase II clinical trials for the treatment of hypoxic tumors). The hCA I was inhibited by compounds 4a-8a with inhibition constants (KI) in the range 93.5-428.1 nM (AAZ and SLC-0111: KI, 250.0 and 5080.0 nM, respectively). Compounds 4a-8a proved to be effective hCA II inhibitors, with KI ranging from 18.2 to 133.3 nM (AAZ and SLC-0111: KI, 12.0 and 960.0 nM, respectively). Compounds 4a-8a effectively inhibited hCA IX, with KI in the range 8.5-24.9 nM; these values are superior or equivalent to that of AAZ and SLC-0111 (KI, 25.0 and 45.0 nM, respectively). Compounds 4a-8a displayed effective hCA XII inhibitory activity with KI values ranging from 8.6 to 43.2 nM (AAZ and SLC-0111: KI, 5.7 and 4.5 nM, respectively). However, compounds 9b-13b and 14c-18c were found to be micromolar CA inhibitors. For molecular docking studies, compounds 5a, 6a, and 8a were selected.
Collapse
Affiliation(s)
- Adel S El-Azab
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
| | - Alaa A-M Abdel-Aziz
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
| | - Silvia Bua
- Università degli Studi di Firenze, Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche, Via U. Schiff 6, 50019 Sesto Fiorentino, Florence, Italy
| | - Alessio Nocentini
- Università degli Studi di Firenze, Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche, Via U. Schiff 6, 50019 Sesto Fiorentino, Florence, Italy
| | - Mohammed M Alanazi
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
| | - Nawaf A AlSaif
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
| | - Ibrahim A Al-Suwaidan
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
| | - Mohamed M Hefnawy
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
| | - Claudiu T Supuran
- Università degli Studi di Firenze, Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche, Via U. Schiff 6, 50019 Sesto Fiorentino, Florence, Italy.
| |
Collapse
|
24
|
Moi D, Nocentini A, Deplano A, Balboni G, Supuran CT, Onnis V. Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation. Eur J Med Chem 2019; 182:111638. [PMID: 31472471 DOI: 10.1016/j.ejmech.2019.111638] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2019] [Revised: 08/21/2019] [Accepted: 08/21/2019] [Indexed: 12/16/2022]
Abstract
Four new series of aromatic sulfamates were synthesized and investigated for the inhibition of four human (h) isoforms of zinc enzyme carbonic anhydrase (CA, EC 4.2.1.1), hCA I, II, IX, and XII. The reported derivatives, obtained by a sulfamoylation reaction of the corresponding phenolic precursors, bear 3,5-diarylpyrazoline moieties as spacers between the benzenesulfamate fragment which binds the zinc ion from the active site, and the tail of the inhibitor. Pyrazolines are biologically privileged scaffolds, endowed with versatile biological activity, such as an anti-proliferative action. The derivatives were tested for the inhibition of the cytosolic, hCA I and II (off target isoforms) and the trans-membrane, tumor-associated hCA IX and XII enzymes (anticancer drug targets). Generally, hCA I was not effectively inhibited, whereas many low nanomolar inhibitors were evidenced against hCA II (KIs in the range of 0.42-90.1 nM), IX (KIs in the range of 0.72-63.6 nM), and XII (KIs in the range of 0.88-85.2 nM). The best substitution fragments at the pyrazoline ring included for CA II a 4-sulfamic group on the 3-aryl and halogens on the 5-aryl or a methoxy group on the 3-aryl and a 4-sulfamate group on the 5-aryl; for CA IX and CA XII they included the sulfamic group on the 3- or 4-position of the 5-aryl and an electronwithdrawing group on the 4-postion of the 3-aryl ring.
Collapse
Affiliation(s)
- Davide Moi
- Department of Life and Environmental Sciences, Unit of Pharmaceutical, Pharmacological and Nutraceutical Sciences, University of Cagliari, via Ospedale 72, Cagliari I, 09124, Italy
| | - Alessio Nocentini
- Department NEUROFARBA - Pharmaceutical and Nutraceutical Section, University of Firenze, via Ugo Schiff 6, I-50019, Sesto Fiorentino, Firenze, Italy
| | - Alessandro Deplano
- Pharmacelera, Placa Pau Vila, 1, Sector 1, Edificio Palau de Mar, Barcelona, 08039, Spain
| | - Gianfranco Balboni
- Department of Life and Environmental Sciences, Unit of Pharmaceutical, Pharmacological and Nutraceutical Sciences, University of Cagliari, via Ospedale 72, Cagliari I, 09124, Italy
| | - Claudiu T Supuran
- Department NEUROFARBA - Pharmaceutical and Nutraceutical Section, University of Firenze, via Ugo Schiff 6, I-50019, Sesto Fiorentino, Firenze, Italy.
| | - Valentina Onnis
- Department of Life and Environmental Sciences, Unit of Pharmaceutical, Pharmacological and Nutraceutical Sciences, University of Cagliari, via Ospedale 72, Cagliari I, 09124, Italy.
| |
Collapse
|
25
|
Kocyigit UM, Budak Y, Gürdere MB, Dürü N, Taslimi P, Gülçin İ, Ceylan M. Synthesis and investigation of anticancer, antibacterial activities and carbonic anhydrase, acetylcholinesterase inhibition profiles of novel (3aR,4S,7R,7aS)-2-[4-[1-acetyl-5-(aryl/heteroaryl)-4,5-dihydro-1H-pyrazol-3-yl]phenyl]-3a,4,7,7a-tetrahydro-1H-4,7-methanoisoindole-1,3(2H)-diones. MONATSHEFTE FUR CHEMIE 2019. [DOI: 10.1007/s00706-019-2350-z] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
|
26
|
Arslan T. Synthesis and Characterisation of New Sulfonamide Chalcones Containing an azo Group. JOURNAL OF CHEMICAL RESEARCH 2018. [DOI: 10.3184/174751918x15269091219930] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The synthesis and characterisation of a new type of chalcone bearing a –N=N– bond is reported using an environmentally benign approach. The synthesis consists of two steps. ( E)-4-((5-acetyl-2-hydroxyphenyl)diazenyl)benzenesulfonamide was synthesised by an easy structural modification of sulfanilamide. The key step then involved the solvent-free Claisen–Schmidt condensation of benzaldehydes to form the chalcones. The structures of all compounds were confirmed by FTIR, NMR and MS spectroscopy.
Collapse
Affiliation(s)
- Tayfun Arslan
- Department of Chemistry, Art and Science Faculty, Giresun University, 28200-Giresun, Turkey Department of Textile, Technical Sciences Vocational School, Giresun University, 28049-Giresun, Turkey
| |
Collapse
|
27
|
Nocentini A, Moi D, Balboni G, Salvadori S, Onnis V, Supuran CT. Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy. Bioorg Chem 2018; 77:633-639. [PMID: 29502024 DOI: 10.1016/j.bioorg.2018.02.021] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2018] [Revised: 02/20/2018] [Accepted: 02/21/2018] [Indexed: 02/04/2023]
Abstract
Herein we report the synthesis of a new series of aromatic sulfamates designed considering the sulfonamide COX-2 selective inhibitors celecoxib and valdecoxib as lead compounds. These latter were shown to possess important human carbonic anhydrase (CA, EC 4.2.1.1) inhibitory properties, with the inhibition of the tumor-associated isoform hCA IX likely being co-responsible of the celecoxib anti-tumor effects. Bioisosteric substitution of the pyrazole or isoxazole rings from these drugs with the pyrazoline one was considered owing to the multiple biological activities ascribed to this latter heterocycle and paired with the replacement of the sulfonamide of celecoxib and valdecoxib with its equally potent bioisoster sulfamate. The synthesized derivatives were screened for the inhibition of four human carbonic anhydrase isoforms, namely hCA I, II, IV, and IX. All screened sulfamates exhibited great potency enhancement in inhibiting isoform II and IV, widely involved in glaucoma (KIs in the range of 0.4-12.4 nM and 17.7 and 43.3 nM, respectively), compared to the lead compounds, whereas they affected the tumor-associated hCA IX as potently as celecoxib.
Collapse
Affiliation(s)
- Alessio Nocentini
- Department NEUROFARBA - Pharmaceutical and Nutraceutical Section, University of Firenze, via Ugo Schiff 6, I-50019 Sesto Fiorentino, Firenze, Italy.
| | - Davide Moi
- Department of Life and Environmental Sciences - Unit of Pharmaceutical, Pharmacological and Nutraceutical Sciences, University of Cagliari, via Ospedale 72, I-09124 Cagliari, Italy
| | - Gianfranco Balboni
- Department of Life and Environmental Sciences - Unit of Pharmaceutical, Pharmacological and Nutraceutical Sciences, University of Cagliari, via Ospedale 72, I-09124 Cagliari, Italy
| | - Severo Salvadori
- Department of Chemical and Pharmaceutical Sciences and LTTA, University of Ferrara, via Fossato di Mortara 17/19, I-44100 Ferrara, Italy
| | - Valentina Onnis
- Department of Life and Environmental Sciences - Unit of Pharmaceutical, Pharmacological and Nutraceutical Sciences, University of Cagliari, via Ospedale 72, I-09124 Cagliari, Italy.
| | - Claudiu T Supuran
- Department NEUROFARBA - Pharmaceutical and Nutraceutical Section, University of Firenze, via Ugo Schiff 6, I-50019 Sesto Fiorentino, Firenze, Italy
| |
Collapse
|
28
|
Arslan T, Biyiklioglu Z, Şentürk M. The synthesis of axially disubstituted silicon phthalocyanines, their quaternized derivatives and first inhibitory effect on human cytosolic carbonic anhydrase isozymes hCA I and II. RSC Adv 2018; 8:10172-10178. [PMID: 35540484 PMCID: PMC9078821 DOI: 10.1039/c7ra13674a] [Citation(s) in RCA: 32] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2017] [Accepted: 03/04/2018] [Indexed: 11/23/2022] Open
Abstract
In this study a novel silicon(iv) phthalocyanine bearing [(2E)-3-[4-(dimethylamino)phenyl]-1-(4-phenoxy)prop-2-en-1-one] group and its quaternized derivative at their axial positions were synthesized for the first time. Axially disubstituted silicon(iv) phthalocyanines were also characterized by various spectroscopic techniques. The inhibition of two human cytosolic carbonic anhydrase (hCA, EC 4.2.1.1) isozymes I and II, with axially disubstituted silicon phthalocyanines and their quaternized derivatives were investigated by using the esterase assay, with 4-nitrophenyl acetate as substrate. Silicon phthalocyanines ZM-1-Si, ZM-5-Si, ZT-Si and their quaternized derivatives ZM-1-SiQ, ZM-5-SiQ, ZT-SiQ showed IC50 values in the range of 0.0178–0.1653 μM for hCA I and of 0.0172–0.1212 μM against hCA II, respectively. This study is the first example of carbonic anhydrase enzyme inhibition of phthalocyanines. In this study a novel silicon(iv) phthalocyanine bearing [(2E)-3-[4-(dimethylamino)phenyl]-1-(4-phenoxy)prop-2-en-1-one] group and its quaternized derivative at their axial positions were synthesized for the first time.![]()
Collapse
Affiliation(s)
- Tayfun Arslan
- Department of Chemistry
- Faculty of Sciences
- Giresun
- Turkey
- Department of Textile
| | - Zekeriya Biyiklioglu
- Department of Chemistry
- Faculty of Science
- Karadeniz Technical University
- 61080 Trabzon
- Turkey
| | - Murat Şentürk
- Department of Basic Sciences of Pharmacy
- Faculty of Pharmacy
- Agri Ibrahim Cecen University
- 04100 Agri
- Turkey
| |
Collapse
|
29
|
Kocyigit UM, Budak Y, Eligüzel F, Taslimi P, Kılıç D, Gulçin İ, Ceylan M. Synthesis and Carbonic Anhydrase Inhibition of Tetrabromo Chalcone Derivatives. Arch Pharm (Weinheim) 2017; 350. [DOI: 10.1002/ardp.201700198] [Citation(s) in RCA: 36] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2017] [Revised: 09/28/2017] [Accepted: 10/04/2017] [Indexed: 12/20/2022]
Affiliation(s)
- Umit M. Kocyigit
- Vocational School of Health Services; Cumhuriyet University; Sivas Turkey
| | - Yakup Budak
- Department of Chemistry; Faculty of Arts and Sciences; Gaziosmanpasa University; Tokat Turkey
| | - Fikret Eligüzel
- Vocational School of Health Services; Cumhuriyet University; Sivas Turkey
| | - Parham Taslimi
- Department of Chemistry; Faculty of Science; Atatürk University; Erzurum Turkey
| | - Deryanur Kılıç
- Department of Chemistry; Art and Science Faculty; Aksaray University; Aksaray Turkey
| | - İlhami Gulçin
- Department of Chemistry; Faculty of Science; Atatürk University; Erzurum Turkey
| | - Mustafa Ceylan
- Department of Chemistry; Faculty of Arts and Sciences; Gaziosmanpasa University; Tokat Turkey
| |
Collapse
|
30
|
Synthesis and pharmacological properties of chalcones: a review. RESEARCH ON CHEMICAL INTERMEDIATES 2017. [DOI: 10.1007/s11164-017-2977-5] [Citation(s) in RCA: 57] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
31
|
Kocyigit UM, Budak Y, Gürdere MB, Tekin Ş, Köprülü TK, Ertürk F, Özcan K, Gülçin İ, Ceylan M. Synthesis, characterization, anticancer, antimicrobial and carbonic anhydrase inhibition profiles of novel (3aR,4S,7R,7aS)-2-(4-((E)-3-(3-aryl)acryloyl) phenyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoisoindole-1,3(2H)-dione derivatives. Bioorg Chem 2016; 70:118-125. [PMID: 28043719 DOI: 10.1016/j.bioorg.2016.12.001] [Citation(s) in RCA: 76] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2016] [Revised: 12/02/2016] [Accepted: 12/05/2016] [Indexed: 01/19/2023]
Abstract
In the present study, a series of new hybrid compounds containing chalcone and methanoisoindole units 7a-n ((3aR,4S,7R,7aS)-2-(4-((E)-3-(3-aryl)acryloyl) phenyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoisoindole-1,3(2H)-dione) were synthesized, characterized and investigated for their anticancer activity against C6 gliocarcinoma cell in rats, and antimicrobial activity against some human pathogen microorganisms. The compounds 7e, 7h, 7j, 7k, 7L and 7n showed very high anticancer activity with the inhibition range of 80.51-97.02% compared to 5-FU. Some of the compounds exhibited anti-microbial activity. Also, they evaluated for inhibition effects against human carbonic anhydrase I, and II isoenzymes (hCA I and II) with Ki values in the range of 405.26-635.68pM for hCA I, and 245.40-489.60pM for hCA II, respectively. These results demonstrated that 3aR,4S,7R,7aS)-2-(4-((E)-3-(3-aryl)acryloyl)phenyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoisoindole-1,3(2H)-dione derivatives could be used in different biomedical applications.
Collapse
Affiliation(s)
- Umit M Kocyigit
- Cumhuriyet University, Vocational School of Health Services, 58140 Sivas, Turkey.
| | - Yakup Budak
- Department of Chemistry, Faculty of Arts and Sciences, Gaziosmanpasa University, 60250 Tokat, Turkey.
| | - Meliha Burcu Gürdere
- Department of Chemistry, Faculty of Arts and Sciences, Gaziosmanpasa University, 60250 Tokat, Turkey
| | - Şaban Tekin
- Department of Molecular Biology and Genetics, Faculty of Arts and Sciences, Gaziosmanpasa University, 60250 Tokat, Turkey
| | - Tuğba Kul Köprülü
- Department of Molecular Biology and Genetics, Faculty of Arts and Sciences, Gaziosmanpasa University, 60250 Tokat, Turkey
| | - Fatih Ertürk
- Department of Chemistry, Faculty of Arts and Sciences, Gaziosmanpasa University, 60250 Tokat, Turkey
| | - Kezban Özcan
- Department of Chemistry, Faculty of Arts and Sciences, Gaziosmanpasa University, 60250 Tokat, Turkey
| | - İlhami Gülçin
- Department of Chemistry, Faculty of Science, Atatürk University, 25240 Erzurum, Turkey; Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia
| | - Mustafa Ceylan
- Department of Chemistry, Faculty of Arts and Sciences, Gaziosmanpasa University, 60250 Tokat, Turkey
| |
Collapse
|